Community Pharmacist Cholesterol Point of Care Screening with Framingham Risk Score
Canadian Pharmacists Conference ePoster Library. Bron L. 06/04/17; 174274; 79
Laura Bron
Laura Bron
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Rate & Comment (0)

Point-of- care cholesterol screening is a valuable tool that community pharmacists can use to identify and educate patients at risk for hypercholesterolemia, cardiovascular disease and related events. Here, we report data from screening 112 patients at structured cholesterol-screening clinics held in the community of Thunder Bay, ON.

The CardioCheck Cholesterol Monitor was used to do a point-of-care calculation of a patient's HDL and Total cholesterol. A minute amount of blood from the finger was needed to run the test. Patients were screened for conditions that place them at higher risk of a cardiovascular event (hypertension, past myocardial infarction or transient ischemic attack, diabetes, smoking). Patients' ten-year risk assessment of a cardiovascular event was calculated using the Framingham Risk Score. Data collection took place over a year.

Testing successfully identified patients potentially at risk for experiencing a cardiovasculalr event in the next ten years. The average total cholesterol was 4.88mmol/L and HDL was 1.04mmol/L. The average Framingham Risk Score was 18.6%. The majority of patients were not maintaining the requirements of having 150 minutes of moderate exercise per week. Smoking cessation and decreasing alcohol and caffeine intake were also discussed.

These results illustrate the prevalence of potentially undiagnosed hypercholesterolemia for patients in the community. Our intervention data suggests that a structured cholesterol and cardiovascular consultation by a community pharmacist can identify patients at risk for experiencing an event. Patients at low risk were given evidence based and practical recommendations to maintain their cardiovascular health and reduce the risk of developing any related diseases. Patients with moderate and high risk were given instruction to visit their primary care practitioner (physician, nurse practitioner) to discuss the results and inquire about possible prescription medication. Continued expansion in scope of pharmacy practice may contribute to increased hypercholesterolemia detection and reduced cardiovascular events.

    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Save Settings